Barone, E. ., Mancuso, C. ., Di Domenico, F. ., Sultana, R. ., Murphy, M. ., Head, E. ., & Butterfield, D. . (2012). Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. Journal of Neurochemistry, 120(1), 135-46. https://doi.org/10.1111/j.1471-4159.2011.07538.x

Duncan, M. ., Guerriero, L. ., Köhler, K. ., Beechem, L. ., Gillis, B. ., Salisbury, F. ., … Murphy, M. . (2022). Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer’s Disease. Neuroscience, 481, 111-122. https://doi.org/10.1016/j.neuroscience.2021.11.042 (Original work published 2022)

Malec, J. ., Salisbury, D. ., Anders, D. ., Dennis, L. ., Groff, A. ., Johnson, M. ., … Smith, G. . (2021). Response to the COVID-19 Pandemic Among Posthospital Brain Injury Rehabilitation Providers. Archives of Physical Medicine and Rehabilitation, 102(3), 549-555. https://doi.org/10.1016/j.apmr.2020.10.137

Weidner, A. ., Bradley, M. ., Beckett, T. ., Niedowicz, D. ., Dowling, A. ., Matveev, S. ., … Murphy, M. . RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer’s disease. PloS One, 6(9), e24930. https://doi.org/10.1371/journal.pone.0024930 (Original work published 2011)

Sompol, P. ., Furman, J. ., Pleiss, M. ., Kraner, S. ., Artiushin, I. ., , … Norris, C. . (2017). Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 37(25), 6132-6148. https://doi.org/10.1523/JNEUROSCI.0877-17.2017 (Original work published 2017)

Bradley-Whitman, M. ., Timmons, M. ., Beckett, T. ., Murphy, M. ., Lynn, B. ., & Lovell, M. . (2014). Nucleic acid oxidation: an early feature of Alzheimer’s disease. Journal of Neurochemistry, 128(2), 294-304. https://doi.org/10.1111/jnc.12444

Lovell, M. ., Lynn, B. ., Fister, S. ., Bradley-Whitman, M. ., Murphy, M. ., Beckett, T. ., & Norris, C. . (2016). A Novel Small Molecule Modulator of Amyloid Pathology. Journal of Alzheimer’s Disease : JAD, 53(1), 273-87. https://doi.org/10.3233/JAD-151160 (Original work published 2016)

Lange, M. B., St Clair, D. ., Markesbery, W. ., Studzinski, C. ., Murphy, M. ., & Butterfield, D. . (2010). Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease. Neurobiology of Disease, 38(1), 104-15. https://doi.org/10.1016/j.nbd.2010.01.004

Aluise, C. ., Robinson, R. ., Beckett, T. ., Murphy, M. ., Cai, J. ., Pierce, W. ., … Butterfield, D. . (2010). Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiology of Disease, 39(2), 221-8. https://doi.org/10.1016/j.nbd.2010.04.011

Butterfield, D. ., Barone, E. ., Di Domenico, F. ., Cenini, G. ., Sultana, R. ., Murphy, M. ., … Head, E. . (2012). Atorvastatin treatment in a dog preclinical model of Alzheimer’s disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain. The International Journal of Neuropsychopharmacology, 15(7), 981-7. https://doi.org/10.1017/S1461145711001118